Sildenafil: medical advance or media event?

Lancet. 1998 May 30;351(9116):1599-600. doi: 10.1016/S0140-6736(05)77682-0.
No abstract available

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors*
  • Administration, Oral
  • Contraindications
  • Drug Utilization
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Male
  • Penile Erection / drug effects
  • Phosphodiesterase Inhibitors / adverse effects
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Purines
  • Sildenafil Citrate
  • Sulfones

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate
  • 3',5'-Cyclic-GMP Phosphodiesterases